We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Nanoparticle Gold-Filled Silicon Wafers Effectively Kill Breast Cancer Cells

By LabMedica International staff writers
Posted on 02 Feb 2012
Print article
Heat generated when hollow gold nanoparticles embedded in silicon nanowafers were exposed to infrared light effectively killed breast cancer cells in vitro and in a mouse model.

Investigators at The Methodist Hospital Research Institute (Houston, TX, USA) created the highly efficient thermal transfer nanoparticles by confining gold nanoshells into nanopores of silicon microparticles. In the presence of infrared light at 808 nm, the gold-filled silicon particles heated up a surrounding aqueous solution by about 20 °C in seven minutes.

Hollow gold responds to near-infrared (NIR) light, which is able to penetrate deeply inside the body and which causes less damage to tissues compared to shorter wavelength light due to less absorbance by the tissue chromophores.

The investigators used human and mouse breast-cancer lines to test cell killing in vitro and the mouse model of 4T1 mammary tumor for in vivo studies. They reported in the January 3, 2012, online edition of the journal Advanced Healthcare Materials that the nanoparticles effectively killed cancer cells both in vitro and in the mouse model.

“Hollow gold nanoparticles can generate heat if they are hit with a near-infrared laser,” said first author Dr. Haifa Shen, assistant research member at The Methodist Hospital Research Institute. “Multiple investigators have tried to use gold nanoparticles for cancer treatment, but the efficiency has not been very good – they would need a lot of gold nanoparticles to treat a tumor. We found that heat generation was much more efficient when we loaded gold nanoparticles into porous silicon, the carrier of the multistage vectors.”

“The hollow gold particles we load into the porous silicon must be the right size and have the correct-sized space inside them to interact with the infrared light we are using,” said Dr. Shen. “But the wavelength of infrared we use will have to change depending on where the tumor is. If it is close to the skin, we can use shorter wavelengths. Deeper inside the body, we have to use longer wavelengths of infrared to penetrate the tissue. The hollow space of the gold particles must be modified in response to that. We are planning preclinical studies to study the technology's impact on whole tissues, breast cancer cells, and possibly pancreatic cancer cells. We would also like to see whether this approach makes chemotherapy more effective, meaning you could use less drugs to achieve the same degree of success in treating tumors. These investigations are next.”

Related Links:

The Methodist Hospital Research Institute

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.